Dr Martens holds firm on guidance despite ‘challenging’ UK market
Ahead of its annual general meeting, footwear retailer Dr Martens said it is trading “in line with expectations” so far during this financial year and confirmed that all guidance for the 2026 financial year remains unchanged.
The footwear specialist said its autumn/winter order books globally are “healthy” and its performance is anticipated to be weighted to the second half, “particularly from a profit perspective”.
Already have an account? Sign in here